In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...
The TELUS Health 2026 Drug Data Trends & National Benchmarks Report, released today at the TELUS Health Annual Conference reveals a surge in private drug plan use is causing a sharp rise in high-cost ...
Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.
Canada has approved Dr Reddy's generic semaglutide injection for diabetes, marking the first G7 approval, promising cost savings and effective treatment.
Health Canada has authorised the first generic version of semaglutide in Canada and across the G7, a move that could lower ...
Health Canada approved on Tuesday the first generic version of Danish drugmaker Novo Nordisk's Ozempic drug.
April 28 (Reuters) - Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic made by Indian drugmaker Dr Reddy's Laboratories, its ...
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the ...
Pharmacy Brands Canada (PBC) today announced the launch of OpenRx, a zero-fee model designed to give independent pharmacy ...
On June 19, 2025, Canada’s Drug Agency (“CDA”) opened a public consultation to gather input on a proposed list of essential prescription drugs and related products. This initiative is part of the ...
People shouldn’t buy or use unauthorized, injectable peptide drugs claiming to help with body issues and wellness, warns Health Canada — they can come with serious side effects.
Critics say the government does not give effective strategies enough time or money to scale up and deliver robust outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results